Skip to main content
Top
Published in: BMC Surgery 1/2015

Open Access 01-12-2015 | Case report

Salvage surgery after chemotherapy with S-1 plus cisplatin for α-fetoprotein-producing gastric cancer with a portal vein tumor thrombus: a case report

Authors: Shigetomi Nakao, Bunzo Nakata, Masashige Tendo, Kenji Kuroda, Takeshi Hori, Mayumi Inaba, Kosei Hirakawa, Tetsuro Ishikawa

Published in: BMC Surgery | Issue 1/2015

Login to get access

Abstract

Background

Patient with α-Fetoprotein (AFP)-producing gastric cancer usually has a short survival time due to frequent hepatic and lymph node metastases. Gastric cancer with portal vein tumor thrombus (PVTT) is rare and has an extremely poor prognosis.

Case presentation

A 63-year-old man was found to have a huge Type 3 gastric cancer with a PVTT and a highly elevated serum AFP level. Chemotherapy with S-1 plus cisplatin was given to this patient with unresectable gastric cancer for 4 months. The serum AFP level decreased from 6,160 ng/mL to 60.7 ng/mL with chemotherapy. Since the PVTT disappeared after the chemotherapy, the patient underwent total gastrectomy. Histological findings of the primary tumor after chemotherapy showed poorly differentiated adenocarcinoma without hepatoid cells and viable tumor cells remaining in less than 1/3 of the neoplastic area of mucosa and one lymph node. The cancerous cells were immunohistochemically stained by anti-AFP antibody. The patient has survived for 48 month without recurrence.

Conclusions

AFP-producing gastric cancer with a PVTT has an extremely poor prognosis, but long-term survival was achieved for this dismal condition by salvage surgery after chemotherapy.
Literature
1.
go back to reference Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H, et al.: Clinicopathologic features of gastric cancers producing alpha-fetoprotein.Dig Surg 2002, 19:359–365. 10.1159/000065838CrossRefPubMed Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H, et al.: Clinicopathologic features of gastric cancers producing alpha-fetoprotein.Dig Surg 2002, 19:359–365. 10.1159/000065838CrossRefPubMed
2.
go back to reference Adachi Y, Tsuchihashi J, Shiraishi N, Yasuda K, Etoh T, Kitano S: AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients.Oncology 2003, 65:95–101. 10.1159/000072332CrossRefPubMed Adachi Y, Tsuchihashi J, Shiraishi N, Yasuda K, Etoh T, Kitano S: AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients.Oncology 2003, 65:95–101. 10.1159/000072332CrossRefPubMed
3.
go back to reference Ishigami S, Natsugoe S, Nakashima H, Tokuda K, Nakajo A, Okumura H, et al.: Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer.Hepatogastroenterology 2006, 53:338–341.PubMed Ishigami S, Natsugoe S, Nakashima H, Tokuda K, Nakajo A, Okumura H, et al.: Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer.Hepatogastroenterology 2006, 53:338–341.PubMed
4.
go back to reference Inoue M, Sano T, Kuchiba A, Taniguchi H, Fukagawa T, Katai H: Long-term results of gastrectomy forα-fetoprotein-producing gastric cancer.Br J Surg 2010, 97:1056–1061. 10.1002/bjs.7081CrossRefPubMed Inoue M, Sano T, Kuchiba A, Taniguchi H, Fukagawa T, Katai H: Long-term results of gastrectomy forα-fetoprotein-producing gastric cancer.Br J Surg 2010, 97:1056–1061. 10.1002/bjs.7081CrossRefPubMed
5.
go back to reference Takahashi Y, Ohta T, Mai M: Angiogenesis of AFP producing gastric carcinoma: correlation with frequent liver metastasis and its inhibition by anti-AFP antibody.Oncol Rep 2004, 11:809–813.PubMed Takahashi Y, Ohta T, Mai M: Angiogenesis of AFP producing gastric carcinoma: correlation with frequent liver metastasis and its inhibition by anti-AFP antibody.Oncol Rep 2004, 11:809–813.PubMed
6.
go back to reference Kamei S, Kono K, Amemiya H, Takahashi A, Sugai H, Ichihara F, et al.: Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein.J Gastroenterol 2003, 38:540–547.PubMed Kamei S, Kono K, Amemiya H, Takahashi A, Sugai H, Ichihara F, et al.: Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein.J Gastroenterol 2003, 38:540–547.PubMed
7.
go back to reference Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H: High frequency of c-Met expression in gastric cancers producing alpha-fetoprotein.Oncology 2000, 59:145–151. 10.1159/000012152CrossRefPubMed Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H: High frequency of c-Met expression in gastric cancers producing alpha-fetoprotein.Oncology 2000, 59:145–151. 10.1159/000012152CrossRefPubMed
8.
go back to reference Kataoka H, Miura Y, Joh T, Seno K, Tada T, Tamaoki T, et al.: α-Fetoprotein producing gastric cancer lacks transcription factor ATBF1.Oncogene 2001, 20:869–873. 10.1038/sj.onc.1204160CrossRefPubMed Kataoka H, Miura Y, Joh T, Seno K, Tada T, Tamaoki T, et al.: α-Fetoprotein producing gastric cancer lacks transcription factor ATBF1.Oncogene 2001, 20:869–873. 10.1038/sj.onc.1204160CrossRefPubMed
9.
go back to reference Fujii H, Ichikawa K, Takagaki T, Nakanishi Y, Ikegami M, Hirose S, et al.: Genetic evolution of alpha fetoprotein producing gastric cancer.J Clin Pathol 2003, 56:942–949. 10.1136/jcp.56.12.942CrossRefPubMedPubMedCentral Fujii H, Ichikawa K, Takagaki T, Nakanishi Y, Ikegami M, Hirose S, et al.: Genetic evolution of alpha fetoprotein producing gastric cancer.J Clin Pathol 2003, 56:942–949. 10.1136/jcp.56.12.942CrossRefPubMedPubMedCentral
10.
go back to reference Kinjo T, Taniguchi H, Kushima R, Sekine S, Oda I, Saka M, et al.: Histologic and immunohistochemical analyses of α-fetoprotein-producing-cancer of the stomach.Am J Surg Pathol 2012, 36:56–65. 10.1097/PAS.0b013e31823aafecCrossRefPubMed Kinjo T, Taniguchi H, Kushima R, Sekine S, Oda I, Saka M, et al.: Histologic and immunohistochemical analyses of α-fetoprotein-producing-cancer of the stomach.Am J Surg Pathol 2012, 36:56–65. 10.1097/PAS.0b013e31823aafecCrossRefPubMed
11.
go back to reference Liu X, Sheng W, Wang Y: An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.J Surg Oncol 2012, 106:299–303. 10.1002/jso.23073CrossRefPubMed Liu X, Sheng W, Wang Y: An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.J Surg Oncol 2012, 106:299–303. 10.1002/jso.23073CrossRefPubMed
12.
go back to reference Ando E, Tanaka M, Yamashita F, Kuromatsu R, Yutani S, Fukumori K, et al.: Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Analysis of 48 cases.Cancer 2002, 95:588–595. 10.1002/cncr.10694CrossRefPubMed Ando E, Tanaka M, Yamashita F, Kuromatsu R, Yutani S, Fukumori K, et al.: Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Analysis of 48 cases.Cancer 2002, 95:588–595. 10.1002/cncr.10694CrossRefPubMed
13.
go back to reference Tanaka A, Takeda R, Mukaihara S, Hayakawa K, Takasu K, Terajima H, et al.: Tumor thrombi in the portal vein system originating from gastrointestinal tract cancer.J Gastroenterol 2002, 37:220–228. 10.1007/s005350200025CrossRefPubMed Tanaka A, Takeda R, Mukaihara S, Hayakawa K, Takasu K, Terajima H, et al.: Tumor thrombi in the portal vein system originating from gastrointestinal tract cancer.J Gastroenterol 2002, 37:220–228. 10.1007/s005350200025CrossRefPubMed
14.
go back to reference Katagiri S, Yamamoto M: Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus.Surg Today 2014, 44:219–226. 10.1007/s00595-013-0585-6CrossRefPubMed Katagiri S, Yamamoto M: Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus.Surg Today 2014, 44:219–226. 10.1007/s00595-013-0585-6CrossRefPubMed
15.
go back to reference The Japanese Society of Pathology (Ed): Annual of the pathological autopsy cases in Japan [in Japanese]. Aichi: Jinshikai; 1998. The Japanese Society of Pathology (Ed): Annual of the pathological autopsy cases in Japan [in Japanese]. Aichi: Jinshikai; 1998.
16.
go back to reference Eom BW, Lee JH, Lee JS, Kim MJ, Ryu KW, Choi IJ, et al.: Survival analysis of gastric cancer patients with tumor thrombus in the portal vein.J Surg Oncol 2012, 105:310–315. 10.1002/jso.22083CrossRefPubMed Eom BW, Lee JH, Lee JS, Kim MJ, Ryu KW, Choi IJ, et al.: Survival analysis of gastric cancer patients with tumor thrombus in the portal vein.J Surg Oncol 2012, 105:310–315. 10.1002/jso.22083CrossRefPubMed
17.
go back to reference Kochi M, Fujii M, Kaiga T, Takahashi T, Morishita Y, Kobayashi M, et al.: FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer.Oncology 2004, 66:445–449. 10.1159/000079498CrossRefPubMed Kochi M, Fujii M, Kaiga T, Takahashi T, Morishita Y, Kobayashi M, et al.: FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer.Oncology 2004, 66:445–449. 10.1159/000079498CrossRefPubMed
18.
go back to reference Japanese Gastric Cancer Association: Japanese gastric cancer treatment guidelines 2010 (ver.3).Gastric Cancer 2011, 14:113–123.CrossRef Japanese Gastric Cancer Association: Japanese gastric cancer treatment guidelines 2010 (ver.3).Gastric Cancer 2011, 14:113–123.CrossRef
19.
go back to reference Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 3 rd English edition.Gastric Cancer 2011, 14:101–112.CrossRef Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 3 rd English edition.Gastric Cancer 2011, 14:101–112.CrossRef
20.
go back to reference Araki T, Suda K, Sekikawa T, Ishii Y, Hihara T, Kachi K: Portal venous tumor thrombosis associated with gastric adenocarcinoma.Radiology 1990, 174:811–814. 10.1148/radiology.174.3.1689502CrossRefPubMed Araki T, Suda K, Sekikawa T, Ishii Y, Hihara T, Kachi K: Portal venous tumor thrombosis associated with gastric adenocarcinoma.Radiology 1990, 174:811–814. 10.1148/radiology.174.3.1689502CrossRefPubMed
21.
go back to reference Lee MW, Lee JY, Kim YJ, Park EA, Choi JY, Kim SH, et al.: Gastric hepatoid adenocarcinoma: CT findings.Abdom Imaging 2007, 32:293–298. 10.1007/s00261-006-9073-4CrossRefPubMed Lee MW, Lee JY, Kim YJ, Park EA, Choi JY, Kim SH, et al.: Gastric hepatoid adenocarcinoma: CT findings.Abdom Imaging 2007, 32:293–298. 10.1007/s00261-006-9073-4CrossRefPubMed
22.
go back to reference Saitoh H, Boku N, Ohtsu A, Hironaka S, Miyamoto S, Hamamoto Y, et al.: Five-year survivor with liver metastasis from gastric cancer successfully treated with systemic chemotherapy.Gastric Cancer 2000, 3:106–109. 10.1007/PL00011694CrossRefPubMed Saitoh H, Boku N, Ohtsu A, Hironaka S, Miyamoto S, Hamamoto Y, et al.: Five-year survivor with liver metastasis from gastric cancer successfully treated with systemic chemotherapy.Gastric Cancer 2000, 3:106–109. 10.1007/PL00011694CrossRefPubMed
23.
go back to reference Yamaguchi M, Midorikawa T, Saitoh M, Kadokura S, Miyagawa K, Sanada Y, et al.: Tumor thrombus in the splenic vein originated from gastric carcinoma that produced α-fetoprotein.Hepatogastroenterology 2003, 50:1693–1696.PubMed Yamaguchi M, Midorikawa T, Saitoh M, Kadokura S, Miyagawa K, Sanada Y, et al.: Tumor thrombus in the splenic vein originated from gastric carcinoma that produced α-fetoprotein.Hepatogastroenterology 2003, 50:1693–1696.PubMed
24.
go back to reference Inoue K, Nakane Y, Kogire M, Fujitani K, Kimura Y, Imamura H, et al.: Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.Eur J Surg Oncol 2012, 38:143–149. 10.1016/j.ejso.2011.11.009CrossRefPubMed Inoue K, Nakane Y, Kogire M, Fujitani K, Kimura Y, Imamura H, et al.: Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.Eur J Surg Oncol 2012, 38:143–149. 10.1016/j.ejso.2011.11.009CrossRefPubMed
25.
go back to reference Iwasaki Y, Sasako M, Yamamoto S, Nakamura K, Sano T, Katai H, et al.: Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210).J Surg Oncol 2013, 107:741–745. 10.1002/jso.23301CrossRefPubMed Iwasaki Y, Sasako M, Yamamoto S, Nakamura K, Sano T, Katai H, et al.: Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210).J Surg Oncol 2013, 107:741–745. 10.1002/jso.23301CrossRefPubMed
Metadata
Title
Salvage surgery after chemotherapy with S-1 plus cisplatin for α-fetoprotein-producing gastric cancer with a portal vein tumor thrombus: a case report
Authors
Shigetomi Nakao
Bunzo Nakata
Masashige Tendo
Kenji Kuroda
Takeshi Hori
Mayumi Inaba
Kosei Hirakawa
Tetsuro Ishikawa
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2015
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/1471-2482-15-5

Other articles of this Issue 1/2015

BMC Surgery 1/2015 Go to the issue